Provided by Tiger Trade Technology Pte. Ltd.

Agree

81.03
-0.7900-0.97%
Post-market: 81.230.2000+0.25%16:14 EST
Volume:1.19M
Turnover:96.01M
Market Cap:9.73B
PE:45.78
High:81.29
Open:81.12
Low:80.45
Close:81.82
52wk High:82.08
52wk Low:68.98
Shares:120.03M
Float Shares:108.37M
Volume Ratio:0.92
T/O Rate:1.10%
Dividend:3.08
Dividend Rate:3.80%
EPS(TTM):1.77
EPS(LYR):1.77
ROE:3.48%
ROA:2.37%
PB:1.60
PE(LYR):45.78

Loading ...

Agree Realty Is Maintained at Buy by Stifel

Dow Jones
·
Feb 11

Evercore ISI Sticks to Their Buy Rating for Agree Realty (ADC)

TIPRANKS
·
Feb 11

Akari Therapeutics Participates in Virtual Investor “What This Means” Interview Discussing the Company’s Expanded ADC Pipeline

GlobeNewswire
·
Feb 11

Sutro Biopharma Highlights ADC Platform in New Presentation

TIPRANKS
·
Feb 11

GUIDANCE: (ADC) Agree Realty Expects Full Year 2026 AFFO Range $4.54 - $4.58

MT Newswires Live
·
Feb 11

Agree Realty Q4 net income per share rises

Reuters
·
Feb 11

Agree Realty reports Q4 AFFO $1.11, consensus $1.10

TIPRANKS
·
Feb 11

Agree Realty sees FY26 AFFO $4.54-$4.58, consensus $4.53

TIPRANKS
·
Feb 11

ADC Q4 net income attributable to common stockholders at USD 54.18 million, up 25%

Reuters
·
Feb 11

Agree Realty Q4 FFO $1.11 Beats $1.10 Estimate, Sales $190.489M Beat $185.501M Estimate

Benzinga
·
Feb 11

BRIEF-Agree Realty Q4 Core FFO Per Share USD 1.1

Reuters
·
Feb 11

Agree Realty Outlook FY Adjusted Ffo per Share USD 4.54-4.58

THOMSON REUTERS
·
Feb 11

Agree Realty: on Track to Achieve 2026 Affo per Share Guidance of $4.54 to $4.58

THOMSON REUTERS
·
Feb 11

Agree Realty Q4 Core Ffo USD 126.8 Million

THOMSON REUTERS
·
Feb 11

U.S. Earnings Preview: After Market Close Feb. 10

Dow Jones
·
Feb 11

Defence Therapeutics Refines Accum ADC Strategy With New Scientific Advisory Board

TIPRANKS
·
Feb 10

Day One To Report Fourth Quarter and Full-Year 2025 Financial Results Tuesday, February 24, 2026

GlobeNewswire
·
Feb 10

Press Release: Sutro Biopharma Announces Pricing of $110.0 million Underwritten Offering

Dow Jones
·
Feb 10

Southwest Securities: Broad Market Potential for Driver Gene-Negative NSCLC, with Dual/Multi-Specific Antibodies and IO+ADC Therapies Advancing Together

Stock News
·
Feb 10

Why Doctors Can't Agree on How to Diagnose Alzheimer's -- Your Health -- WSJ

Dow Jones
·
Feb 10